Malignant melanoma (metastatic)

di Larkin, James, Gore, Martin
Pubblicazione 2008

Renal Cell Cancer: What Can We Learn from Pre-Operative Studies?

di Fisher, Rosalie, Larkin, James
Pubblicazione 2011

Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma

di Fisher, Rosalie, Larkin, James
Pubblicazione 2012

Individualising treatment choices in a crowded treatment algorithm

di Fisher, Rosalie, Larkin, James
Pubblicazione 2013

Renal cell carcinoma and the use of sorafenib

di Larkin, James MG, Eisen, Tim
Pubblicazione 2006

Malignant melanoma (metastatic)

di Fisher, Rosalie Anne, Larkin, James
Pubblicazione 2010

Adrenal insufficiency and checkpoint inhibitors for cancer

di Morganstein, Daniel L, Larkin, James
Pubblicato in Clin Med (Lond) (2020)

Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib

di Vasudev, Naveen S., Larkin, James M.G.
Pubblicazione 2011

Inter and Intratumour Heterogeneity: A Barrier to Individualized Medical Therapy in Renal Cell Carcinoma?

di Fisher, Rosalie, Larkin, James, Swanton, Charles
Pubblicazione 2012

Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity

di Fisher, Rosalie, Larkin, James, Swanton, Charles
Pubblicazione 2011

Experience with sunitinib in the treatment of metastatic renal cell carcinoma

di Schmidinger, Manuela, Larkin, James, Ravaud, Alain
Pubblicazione 2012

Renal cell carcinoma. Translational biology, personalized medicine and novel therapeutic targets

di Vasudev, Naveen S, Larkin, James M G
Pubblicazione 2013

New survival standards for advanced melanoma

di Spain, Lavinia, Larkin, James, Turajlic, Samra
Pubblicato in Br J Cancer (2020)

Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm

di Khattak, Muhammad, Fisher, Rosalie, Turajlic, Samra, Larkin, James
Pubblicazione 2013

Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection

di Flynn, Michael, Pickering, Lisa, Larkin, James, Turajlic, Samra
Pubblicato in Ther Adv Med Oncol (2018)

Future career intentions of recent GP graduates in Ireland: a trend analysis study

di Pericin, Ivana, Mansfield, Gerard, Larkin, James, Collins, Claire
Pubblicato in BJGP Open (2018)

What is the risk of intracranial bleeding during anti-VEGF therapy?

di Carden, Craig P., Larkin, James M.G., Rosenthal, Mark A.
Pubblicazione 2008

Fatigue in Renal Cell Carcinoma: The Hidden Burden of Current Targeted Therapies

di Larkin, James M.G., Pyle, Lynda M., Gore, Martin E.
Pubblicazione 2010

Translational Implications of Tumor Heterogeneity

di Jamal-Hanjani, Mariam, Quezada, Sergio A., Larkin, James, Swanton, Charles
Pubblicato in Clin Cancer Res (2015)

The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK

di Larkin, James, Hatswell, Anthony J., Nathan, Paul, Lebmeier, Maximilian, Lee, Dawn
Pubblicato in PLoS One (2015)